未登录

W

Weng Ng

Liverpool Hospital

H指数:22

被引数:2,075

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials

衡量重要因素：RECIST疗效评价不能预测早期临床试验中的HRQoL

IF4.4

2026-04-170

OAAI

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER

早期肿瘤学临床试验中健康相关生活质量的预期性评估：PEARLER

JNCI CANCER SPECTRUM

IF4.1

2025-12-010

OAAI

Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way Forward

老年人在早期癌症临床试验中的纳入：安全性、有效性与前进方向

IF3.8

2025-10-230

PRE

Prognostic Value of LC3A Protein Expression Patterns in Rectal Cancer Tumors

直肠癌细胞中LC3A蛋白表达模式的预后价值

IF4.4

2025-05-050

OA

Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study

JNCI CANCER SPECTRUM

IF4.1

2025-04-010

PRE

Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn's Colitis Cure Data Insights Program

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-220

PRE

Inflammatory bowel disease helpline use amongst individuals who are culturally and linguistically diverse, Crohn's Colitis Cure Data Insight's Programme

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-220

PRE

Iron deficiency, with or without anaemia, in Inflammatory Bowel Disease remains an undermanaged issue: Crohn's Colitis Cure Data Insights Program

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-220

PRE

Longitudinal measurements of the neutrophil-lymphocyte ratio during treatment for locally advanced rectal cancer and associations with smoking, ethnicity and pathological response

治疗局部晚期直肠癌期间中性粒细胞与淋巴细胞比值的长时程测量及其与吸烟、种族和病理反应的关联

ANNALS OF ONCOLOGY

IF65.4

2024-12-010

PRE

Menetrier's disease exacerbating ulcerative colitis and relieved by gastrectomy

Menetrier病加重溃疡性结肠炎并通过胃切除术缓解

BMJ OPEN GASTROENTEROLOGY

IF2.9

2021-12-200

OAAI

Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature

IF3.9

2021-12-148

OAAI

Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2020-10-2953

OA

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis

IF3.4

2018-09-0364

OAAI

Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients

IF3.4

2017-04-0840

OAAI

The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy

CLINICAL COLORECTAL CANCER

IF3.2

2016-12-0174

PREAI

Adjuvant chemotherapy for stage III colorectal cancer in the elderly

ANNALS OF ONCOLOGY

IF65.4

2016-10-010

OAAI

Change in serum microRNA expression during neoadjuvant chemoradiation for rectal cancer

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Circulating Tumor Cells in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2015-11-011

OAAI

Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2015-10-0142

PREAI

An estimation of population-based survival benefit of first-line chemotherapy for urological cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-010

PREAI